临床实践
Copyright ©The Author(s) 2019.
世界华人消化杂志. 2019-08-08; 27(15): 961-966
在线出版 2019-08-08. doi: 10.11569/wcjd.v27.i15.961
表2 两组患者治疗前后血清炎性因子水平比较(mean ± SD)
测定项目观察组对照组tP
IL-1β (pg/mL)治疗前66.87 ± 15.2165.12 ± 12.640.7070.240
治疗后28.05 ± 10.4244.21 ± 16.23-6.7620.000
IL-6 (pg/mL)治疗前221.63 ± 31.63219.89 ± 35.830.2910.386
治疗后80.98 ± 21.62144.25 ± 26.21-14.8970.000
TNF-α (pg/mL)治疗前182.57 ± 27.35186.37 ± 29.32-0.7580.225
治疗后69.82 ± 11.52139.34 ± 26.21-19.4170.000
IFN-γ (pg/mL)治疗前105.63 ± 27.37108.53 ± 32.54-0.5460.293
治疗后68.48 ± 18.8582.57 ± 21.68-3.9340.000
CRP (mg/L)治疗前28.68 ± 11.0527.84 ± 10.790.4350.332
治疗后11.67 ± 11.5218.66 ± 7.32-4.0970.000

引文著录: 马丽丽, 罗庆盛, 陶金红. 艾司奥美拉唑联合康复新治疗幽门螺杆菌阴性胃溃疡的疗效研究. 世界华人消化杂志 2019; 27(15): 961-966